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Abstract
Background: Metastatic cancer is incurable and understanding the molecular underpinnings is crucial to improving
survival for our patients. The IGF-1/Akt signaling pathway is often impaired in cancer leading to its progression and
metastases. Diet modification is known to alter the IGF-1/Akt pathway and affect the expression of microRNA involved
in tumor initiation, growth and metastases. Liver metastases are one of the most common type of metastases in breast
and colon cancer. In the present study, we looked at the effect of diet modification on the expression of microRNA in
normal liver and liver with breast cancer metastases using in vivo model.
Methodology: 6-month-old C57BL/6 J mice were put on either an ad libitum (AL) diet, or 40% calorie restricted (CR)
diet or were fasted for 24 h (FA) before sacrifice. MicroRNA array analysis, western blot and qRT-PCR were performed
using liver tissue to compare the treatment groups. A breast cancer model was also used to study the changes in
microRNA expression in liver of a group of BALB/c mice orthotopically injected with 4 T1 cells in the mammary fat pad,
put on either an AL or 30% CR diet. Liver and primary tumor tissues were used to perform qRT-PCR to compare the
treatment groups.
Results: MicroRNA array analysis showed significant changes in miRNA expression in both CR and FA conditions in
normal liver. Expression of miR-29 and miR-30 family members was increased in both CR and FA. Western blot analysis
of the normal liver tissue showed that CR and FA downregulated the IGF-1/Akt pathway and qRT-PCR showed that the
expression of miR-29b, miR-29c, miR-30a and miR-30b were increased with CR and FA. Liver tissue collected from mice
in the breast cancer model showed an increase in expression of miR-29b, miR-29c and miR-30b while tumor tissue
showed increased expression of miR-29c, miR-30a and miR-30b.
Discussion: Members of the miR-29 family are known to target and suppress IGF-1, while members of the miR-30
family are known to target and suppress both IGF-1 and IGF-1R. In the present study, we observe that calorie restriction
increased the expression of miR-29 and miR-30 in both the normal liver as well as the liver with breast
cancer metastases. These findings suggest that dietary alterations may play a role in the treatment of liver
metastasis, which should be evaluated further.
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Introduction
Metastatic cancer is associated with disease that has
spread beyond its initial site requiring constant treatment
to prevent disease progression. Patients will ultimately
succumb to metastatic breast cancer from either consequences of the disease or toxicity of treatment including
cardiac toxicities and secondary malignancies. Liver metastases are among the most common types of metastases,
representing more than 50% of breast and colorectal metastases, and are inescapably fatal [1, 2]. Few treatments
exist to restrain these metastases, emphasizing the importance of identifying the novel molecular mechanisms driving them. The liver is a critical nutrient sensor and is rich
in metabolic processes affected by dietary alterations evaluated in prior works [3–5], but has not yet been examined
in the context of metastatic cancer. Caloric restriction
(CR) has previously been shown to play a role in decreasing both primary tumor growth and metastases [6], and
short-term or intermittent fasting have been shown to reproduce many of the physiologic changes observed during
CR, such as slowing tumor growth and incidence [7–9]. It
therefore follows that dietary alterations may play a role in
managing liver metastases.
At the mechanistic level, microRNAs (miRNA), or
small non-coding RNAs, play a role in cancer initiation,
progression and metastases [10–14] and are altered by
dietary interventions like fasting and caloric restriction
[15–18]. In the present study, we used in vivo experiments to determine if dietary alterations affect miRNA
expression in the normal liver or in liver metastases
from breast cancer to identify potential novel targets for
breast cancer liver metastases. We report global microRNA expression changes in liver tissue from normal
mice fed ad libitum (AL), 40% CR diet, or following a
24-h fast. Here we show increased expression of miR-29
and miR-30 family members due to these dietary interventions in the normal liver and breast cancer liver metastases models. Multiple members of each of the
miRNA family directly target and repress the IGF-1/
IGF-1R signaling axis, which is associated with decreased
cancer progression and metastases. Our findings support
the use of dietary intervention in treatment and provide
a novel targeting strategy for therapies in the future.
Materials and methods
Mice and dietary regimen

For the normal mice subjected to ad libitum (AL) feeding or dietary alterations, 15 6-month old C57BL/6 J
mice were obtained through the National Institute of
Aging (NIA) Aged Rodent Program under two feeding
conditions (Charles River) on an Institutional Animal
Care and Use Committee (IACUC) approved mouse
protocol. One group of 10 mice was fed AL diet, and the
remaining 5 mice were fed a calorie restriction (CR) diet
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of 60% normal intake. CR was initiated a week after arrival with a 10% restriction, increased to 25% restriction
the next week, and to 40% restriction the following
week, where it was maintained throughout the life of the
animal. All mice were singly housed throughout the experiment and were fed NIH-31 food fortified with an
NIA supplement for CR mice. Age-matched AL mice
were fasted for 24 h (FA) before sacrifice.
To assess the effect of diet in a murine breast cancer
model, 12-week-old BALB/c mice were acquired from
Charles River Laboratories under an IACUC approved
protocol at Thomas Jefferson University. At 13 weeks, all
mice received orthotopic injections of 50,000 4T1
luciferase-tagged cells (a gift from Patricia Steeg) into the
#4 mammary fat pad. Mice treated with CR were stepped
down to 90% of their baseline chow intake for 5 days,
followed by 2 successive 10% decreases every 5 days until
a 30% total reduction was achieved (LabDiet 5010).
Total RNA purification, array analysis, and real-time PCR

AL, CR, and fasted mice were sacrificed; the liver tissues
were dissected and immediately placed in RNAlater
(Ambion). RNA was isolated from the liver tissue using
Trizol (Invitrogen) method. RNA concentration and quality were determined using Nanodrop and quantitative
real-time PCR (qRT-PCR) was performed (Applied Biosystems 7500 fast) using the miScript SYBR Green PCR
kit and miScript Primer Assay for miR-29 and miR-30
(Qiagen). miRNA levels were normalized to snord68 as an
internal control. miRNA microarray analysis was performed by LC Sciences (Houston, TX) on 5 μg of total
RNA as previously described [19].
Immunoblotting

Total protein was extracted from 50 mg of RNA-later preserved mouse liver tissue. Tissue was added to 1 mL of
SDS lysis buffer (1% SDS, 50 mM Tris pH 8.0, 10 mM
EDTA, Protease inhibiter (Roche), and Halt Phosphatase
Inhibitor (Thermo Scientific) in a lysing matrix D tube
(MP Biomedicals). Tissue was homogenized using manufacturer’s suggested settings for a FastPrep-24 machine
(MP Biomedicals). Samples were sonicated using a probe
sonicator four times for 5 s each on ice and heated at
70 °C for 30 min with mixing. Lysates were cleared by centrifugation at 14,000 x g for 10 min at 4 °C. Protein
concentration was determined using the BCA Protein
Assay (Thermo Scientific). 40 μg of total protein was subjected to SDS-PAGE on a 4–12% gradient Bis-Tris gel
(Invitrogen). Protein was transferred to a 0.2-μm PVDF
membrane using the XCell transfer system (Invitrogen).
Western blots were performed using the following antibodies: IGF-1 (Santa Cruz Biotechnology), IGF-1Rß (Cell
Signaling Technology), phospho-IGF-1R tyrosine 1165/
tyrosine 1166 (Sigma), IRS1 (Cell Signaling Technology),
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(See figure on previous page.)
Fig. 1 Diet modification changes the expressions of multiple microRNA in normal liver tissue of mice. MicroRNA expression patterns were detected by
microarray from total RNA purified from normal liver tissue of C57BL/6 J mice following Ad. Libitum (AL) diet, 40% Caloric restriction (CR) diet or a 24-h
fast (FA). a Heat map clustering of significantly changed microRNAs in normal livers of mice on AL or FA diet. b Heat map clustering of significantly
changed microRNAs in normal livers of mice on AL or CR diet. c Venn diagram showing liver microRNA expression overlap between CR and FA
diet groups

pan AKT (Cell Signaling Technology), phospho-AKT
serine 473(Cell Signaling Technology), GAPDH (Santa
Cruz Biotechnology).

CR increased expression of miR-29 and miR-30 family
members and altered IGF-1 signaling in normal liver

miRNA arrays were performed on 3 samples for each condition. Significance between normalized expressions from
array samples was determined using Student’s t-test and
p < 0.02. Data from the microarray experiments were collected and analyzed in accordance with the MIAME
guidelines. MicroRNA expression profiles were analyzed
using IPA software 9 core analysis function and microRNA target filter. miRNA target prediction was performed
using Targetscan 5.1 and PICTAR. Unless otherwise
stated, data represent the mean of 3 experiments, and
error bars represent standard error of mean.

The microRNA prediction algorithm TargetScan v6.0
and IPA’s miRNA target filter were utilized to identify
predicted targets of the 26 microRNAs altered in both
fasting and CR, yielding > 58,000 predicted targets. To
focus this search, we filtered this gene list for targets of
miR-29 and miR-30 families that are known to be involved in IGF-1 signaling.
miR-29 represses p85 (PIK3R1) [24] and miR-30 targets JUN [25], both of which are important in cancer
progression. We confirmed that multiple members of
the IGF-1 signaling cascade, including pro-IGF-1, IGF1R, IRS1, and phospho-Akt, are reduced in CR liver tissue (Fig. 2a). In CR and fasted tissue, IGF-1 and IGF-1R
were reduced inversely to miR29 and miR-30 expression
as validated by qRT-PCR (Fig. 2a, b and c).

Results

CR increases miR-29 and miR-30 expression in primary
breast tumor and liver tissue with metastases

Bioinformatics and statistics

Array analysis of miRNA changes during caloric restriction
and fasting in mice

We detected global changes in miRNA expression
using liver tissue from age-matched C57BL/6 J mice
fed ad libitum (AL), 40% calorically restricted (CR),
or 24 h fasted (FA) mice analyzed by miRNA arrays.
These arrays show significant alterations in miRNA
expression (Fig. 1a-b) as well as a 73% overlap between CR and FA in the miRNAs changed (Fig. 1c).
Multiple microRNAs belonging to the highly conserved miR-29 and miR-30 families showed significantly increased expression after exposure to both
dietary interventions.
In order to analyze the effect of miRNAs with altered expression in both conditions we used Ingenuity
Pathway analysis (IPA) software’s miRNA target filter
to identify experimentally observed targets reported in
the literature. This list was filtered for miRNAs with
detectable expression in mouse liver tissue in published arrays [20, 21]. Core IPA analysis of the target
list revealed that one of the top networks altered involved cell growth and proliferation centered on IGF1, EGF, and HGF growth factor signaling (Supplementary Figure 1). This is significant since many of the
cancer prevention effects of CR are thought to involve
repression of the pro-proliferation anti-apoptotic IGF1/AKT/mTOR signaling axis [22, 23].

We assessed miR-29 and miR-30 expression in the primary breast tumor and liver tissue with breast cancer
metastases of BALB/c mice fed AL or 30% reduced CR
diets, to determine if CR effects the expression of these
miRNAs. qRT-PCR was performed to survey miR-29
and miR-30 family member expression.CR increased
miR-29b in the liver tissue by 2.5-fold compared to AL
(Fig. 2e(i)) with no change in expression in the tumor
(Fig. 2d(i)). CR also increased the expression of miR-29c
in the tumor and liver tissue by ~ 3.4-fold and ~ 9-fold
respectively (Fig. 2d (ii) and Fig. 2e (ii)). CR caused a
3.5-fold increase in the expression of miR-30a in tumor
(Fig. 2d (iii)) and a 5-fold and 4-fold increase in miR-30b
expression in tumor and liver tissue respectively (Fig. 2d
(iv) and 2E (iv)).

Discussion
Our initial hypothesis that microRNAs play a functional
role in mediating the physiological effects of dietary restriction is supported by our observation of the changes
in the unique global expression patterns of liver microRNAs of calorically restricted (− 40%) or 24-h fasted
C57BL/6 J mice compared to AL controls. It must also
be noted that fasting produces > 2 fold more alterations
to microRNA expression than CR (71 vs. 38). We predict that the larger group of miRNAs altered by fasting
is due to an acute response, while expression changes
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Fig. 2 Diet modification using CR or FA repressed the IGF-1 pathway and altered the expression of miR-29 and miR-30. a Western blot analysis of
IGF-1 pathway proteins from total protein purified from normal liver tissue of C57BL/6 J mice on AL, CR or FA diet. b qRT-PCR for expression of
IGF-1 and IGF-1R in AL, CR, and FA normal liver tissue, mean ± SD (*- p < 0.05, n = 4). c Real time qPCR validation of miR-29b, miR-29c, miR-30a
and miR-30b expression in normal liver of mice on AL, CR or FA diets, mean ± SD (*- p < 0.05, n = 4). d Expression of miR-29b (i), miR-29c (ii), miR30a (iii) and miR-30b (iv) in primary breast cancer tumor of BALB/c mice on AL or CR (30%) diet represented by mean ± SE (***-p < 0.001 and
*-p < 0.05, n = 3). e Expression of miR-29b (i), miR-29c (ii), miR-30a (iii) and miR-30b (iv) in liver tissue with metastases of breast cancer in BALB/c
mice on AL or CR diets, represented by mean ± SE (***-p < 0.001 and *-p < 0.05, n = 3)

detected in the CR group represent stable changes due
to longer-term dietary changes. However, 73% of the
miRNA expression changes that were detected in the CR
group were also altered in the fasted group, suggesting
that they may be mechanistically important in pathways
influenced by dietary alterations.
Systems analysis of experimentally reported targets of
the group of miRNAs that were changed in both conditions using IPA software showed an enrichment in transcripts that, if repressed, would suppress several growth
factor signaling pathways. This observation is in agreement with what is known in general about the cellular
response to dietary restriction, whereby growth and
reproduction is repressed in favor of maintenance and
repair [26]. Expression of several family members of the
miR-29 and miR-30 family was increased in both the
fasted and CR tissues; and are associated with tumor
suppressive processes. Specifically, the miR-29 family
plays an inhibitory role in oncogenic metabolism affecting proliferation, angiogenesis, metastasis, and apoptosis.
miR-29 has been shown to be tumor suppressive in
more than 95% publications based on cancer studies
[27]. Overexpression of miR-29a directly suppressed
IGF-1R in the HepG2 Hepatocellular Carcinoma cellline [28]. Park et al. in an in vitro study showed that
members of the miR-29 family repressed p85α (PI3K)
and upregulated p53 [24]. miR-30 family members act as
both tumor suppressive and oncogenic miRNAs depending on the type of cancer. As a tumor suppressor in
breast cancer, gastric cancer, pancreatic cancer and renal
cell carcinoma, miR-30 prevents proliferation, invasion
and metastasis [29–32] by targeting IGF-1R [31].
Many primary tumors spread to the liver, with greater
than 50% of colorectal tumors metastasizing to the liver
[2]. Other more common cancers that produce liver metastases include breast cancer, lung cancer and pancreatic cancer among others [32]. Since the members of the
miR-29 and miR-30 family repress the IGF-1 signaling
pathway, we explored the capacity of diet to alter metastatic tumor biology. CR increased the expression of
miR-29b, miR-30a and miR-30b in the tumor, and increased expression of miR-29b, miR-29c and miR-30b in
the liver tissue with metastases from breast tumor. We
believe that alterations to miR-30a expression in primary
breast cancers not observed in the liver are due to

differences in the two environments that drive different
expression pathways leading to miR-30 family expression. Here we show that CR leads to increased expression of miR-29 and miR-30 in the both the normal liver,
primary breast tumor and liver with metastases from
BC. Both these microRNAs repress IGF-1, while IGF-1R
was a target of miR-30 alone. These findings are in
agreement with our previous studies in an in vivo
model of triple negative breast cancer (TNBC) that
showed that at both the mRNA and protein level
these genes are downregulated by CR alone or in
combination with other treatments [6, 33]. Diet
modification has also been shown to downregulate
the IGF-1 signaling in other cancers including prostate, pancreatic and colon cancer thereby delaying
their progression [34–36]. Many studies have demonstrated the role of IGF-1/ IGF-1R signaling pathway in invasion and metastasis [37–39].
The liver produces 90% of all IGF-1 and we observe
that CR represses IGF-1 and IGF-1R via regulation by
miR-29 and miR-30. Taken together we hypothesize that
CR combined with other treatment may be able to prevent progression of liver metastasis via the upregulation
of miR-29 and miR-30 and downregulation of the IGF1/AKT/mTOR signaling pathway. Using a dietary intervention to downregulate the IGF-1 pathway could represent an ideal strategy to employ in clinical practice since
the downregulation of this pathway is known to decrease
cancer progression and metastases.

Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s12986-020-00437-z.
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